EUCTR2007-003867-36-IT进行中（未招募）不适用
PILOT STUDY OF PHARMACOGENETICS, CLINICAL EFFICACY AND TOLERABILITY OF CLOZAPINE IN PATIENTS AFFECTED BY SCHIZOPHRENIA, SCHIZOAFFECTIVE DISORDERS AND BIPOLAR DISORDERS WITH PSYCHOTIC FEATURES - ND
AZIENDA OSPEDALIERA PISANA0 个研究点开始时间: 2007年10月9日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Age greater than 18 years and lower than 65 years. Diagnosis of schizophrenia, schizoaffective disorders and bipolar disorders with psychotic features (DSM-IV criteria). Treatment with clozapine since at least 14 days. Patients? agreement to follow up with measurement of clozapine and norclozapine plasma levels. Signature of written informed consent.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Age lower than 18 years or higher than 65 years. Epatic or renal failure. Cardiopathies. Parkinson?s disease; Epilepsy and predisposing conditions. Depressive disorders. Myasthenia gravis. Paralytic ileus. Prostate hyperplasia. Familial or personal case history of glaucoma. Respiratory diseases. Familial or personal case history of jaundice or hematological diseases. Familial or personal case history of photosensitization. Personal case history of substance abuse in the last year. Pregnancy or breast-feeding.
研究者
相似试验
进行中（未招募）
1 期
Clinical study to find out how well wilate works in little children with severe von Willebrand diseaseEUCTR2020-004344-28-DEOctapharma Pharmazeutika Produktionsges.m.b.H.12
招募中
1 期
Clinical study to find out how well wilate works in little children with severe von Willebrand diseaseRoutine prophylaxis in children under the age of 6 years with severe VWDMedDRA version: 20.0Level: LLTClassification code 10055168Term: Von Willebrand's factor deficiencySystem Organ Class: 100000004850EUCTR2020-004344-28-CZOctapharma Pharmazeutika Produktionsges.m.b.H.12
进行中（未招募）
不适用
Study to evaluate the efficacy, metabolism and safety of human immune globulin in patients with primary immunodeficiency diseases.EUCTR2009-011434-10-Outside-EU/EEAOCTAPHARMA AG51
进行中（未招募）
不适用
CLINICAL STUDY TO EVALUATE THE EFFICACY, PHARMACOKINETICS AND SAFETY OF IMMUNOGLOBULIN INTRAVENOUS (HUMAN) 10% (NEWGAM) IN PATIENTS WITH PRIMARY IMMUNODEFICIENCY DISEASESEUCTR2009-011434-10-DEOCTAPHARMA AG50
进行中（未招募）
1 期
A fibrinogen concentrate study in paediatric patients with inherited fibrinogen deficiencyAfibrinogenaemia or severe hypofibrinogenaemiaMedDRA version: 16.1Level: LLTClassification code 10052651Term: AfibrinogenaemiaSystem Organ Class: 100000004850MedDRA version: 16.1Level: PTClassification code 10051125Term: HypofibrinogenaemiaSystem Organ Class: 10005329 - Blood and lymphatic system disordersEUCTR2013-000261-36-FRFB Biotechnologies16